atropine sulfate; diphenoxylate hydrochloride · Pfizer · NDA 012462, 012699
Lomotil
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 012462 · 001 · RLD | tablet, oral | 0.025MG;2.5MG | open |
| 012699 · 001 · discontinued | solution, oral | 0.025MG/5ML;2.5MG/5ML | open |